Modulus Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
Modulus Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $3.8 million sold in a notice filed in 2021.
Modulus Therapeutics at a glance
What does Modulus Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.8 million sold (2021).
Frequently asked questions about Modulus Therapeutics
Where is Modulus Therapeutics headquartered?
Modulus Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Modulus Therapeutics do?
Modulus Therapeutics, Inc. is a biotechnology company.
When was Modulus Therapeutics founded?
The earliest incorporation on record for Modulus Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences